Search research articles
Contact Us
Filters
Showing results (141-150 of 184) with videos related to
Page
of 19
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system
Scott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Journal of Neurovirology
|
August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND
Lisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
The Lancet. HIV
|
October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial
Robert Gross, Lu Zheng, Alberto La Rosa, et al.
Journal of Virology
|
May 20, 2011
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes
Joshua T Herbeck, Morgane Rolland, Yi Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 26, 2022
Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV
Caitlin Wei-Ming Watson, Lily Kamalyan, Bin Tang, et al.
The Journal of Infectious Diseases
|
January 20, 2011
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection
Amie L Meditz, Samantha MaWhinney, Amanda Allshouse, et al.
The New England Journal of Medicine
|
December 3, 2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy
Paul E Sax, Camlin Tierney, Ann C Collier, et al.
The Journal of Clinical Investigation
|
July 16, 2019
Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance
Serena Spudich, Kevin R Robertson, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 1, 2012
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort
Maiko Sakamoto, Thomas D Marcotte, Anya Umlauf, et al.
Plos Pathogens
|
April 12, 2019
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection
Tiffany Hensley-McBain, Michael C Wu, Jennifer A Manuzak, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 184) with videos related to
Sort By:
Page
of 19
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
November 28, 2007
The role of cohort studies in drug development: clinical evidence of antiviral activity of serotonin reuptake inhibitors and HMG-CoA reductase inhibitors in the central nervous system
Scott L Letendre, Jennifer Marquie-Beck, Ronald J Ellis, et al.
Journal of Neurovirology
|
August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND
Lisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
The Lancet. HIV
|
October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial
Robert Gross, Lu Zheng, Alberto La Rosa, et al.
Journal of Virology
|
May 20, 2011
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes
Joshua T Herbeck, Morgane Rolland, Yi Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 26, 2022
Ethnic/Racial Disparities in Longitudinal Neurocognitive Decline in People With HIV
Caitlin Wei-Ming Watson, Lily Kamalyan, Bin Tang, et al.
The Journal of Infectious Diseases
|
January 20, 2011
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection
Amie L Meditz, Samantha MaWhinney, Amanda Allshouse, et al.
The New England Journal of Medicine
|
December 3, 2009
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy
Paul E Sax, Camlin Tierney, Ann C Collier, et al.
The Journal of Clinical Investigation
|
July 16, 2019
Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance
Serena Spudich, Kevin R Robertson, Ronald J Bosch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 1, 2012
Concurrent classification accuracy of the HIV dementia scale for HIV-associated neurocognitive disorders in the CHARTER Cohort
Maiko Sakamoto, Thomas D Marcotte, Anya Umlauf, et al.
Plos Pathogens
|
April 12, 2019
Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection
Tiffany Hensley-McBain, Michael C Wu, Jennifer A Manuzak, et al.
Page
of 19